Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Serum and tissue profiling in bladder cancer combining protein and tissue arrays.

Orenes-Piñero E, Barderas R, Rico D, Casal JI, Gonzalez-Pisano D, Navajo J, Algaba F, Piulats JM, Sanchez-Carbayo M.

J Proteome Res. 2010 Jan;9(1):164-73. doi: 10.1021/pr900273u.

PMID:
19883059
2.

Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach.

Orenes-Piñero E, Cortón M, González-Peramato P, Algaba F, Casal I, Serrano A, Sánchez-Carbayo M.

J Proteome Res. 2007 Nov;6(11):4440-8. Epub 2007 Sep 29.

PMID:
17902641
3.

Bladder cancer outcome and subtype classification by gene expression.

Blaveri E, Simko JP, Korkola JE, Brewer JL, Baehner F, Mehta K, Devries S, Koppie T, Pejavar S, Carroll P, Waldman FM.

Clin Cancer Res. 2005 Jun 1;11(11):4044-55.

4.

[Correlation of clusterin expression to prognosis of bladder carcinoma].

Luo JH, Xie D, Chen W, Dai YP, Li XF, Tao Y, Zheng KL.

Ai Zheng. 2005 Jun;24(6):743-7. Chinese.

PMID:
15946493
5.

Value of clusterin immunoreactivity as a predictive factor in muscle-invasive urothelial bladder carcinoma.

Krüger S, Mahnken A, Kausch I, Feller AC.

Urology. 2006 Jan;67(1):105-9.

PMID:
16413343
6.

Profiling bladder cancer using targeted antibody arrays.

Sanchez-Carbayo M, Socci ND, Lozano JJ, Haab BB, Cordon-Cardo C.

Am J Pathol. 2006 Jan;168(1):93-103.

7.

Autoantibodies against P53 protein in patients with transitional cell carcinoma of the bladder.

Sanchez-Carbayo M, Chulia MT, Niveiro M, Aranda I, Mira A, Soria F.

Anticancer Res. 1999 Jul-Aug;19(4C):3531-7.

PMID:
10629648
8.

[New markers for pharmacological targeting in bladder cancer with lymph node metastasis].

Herrmann E, Eltze E, Köpke T, Bolenz C, Bierer S, Neumann J, Hertle L, Wülfing C.

Aktuelle Urol. 2007 Sep;38(5):392-7. German.

PMID:
17907066
9.

Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles.

Modlich O, Prisack HB, Pitschke G, Ramp U, Ackermann R, Bojar H, Vögeli TA, Grimm MO.

Clin Cancer Res. 2004 May 15;10(10):3410-21.

10.

Immunohistochemical evaluation of nm23-H1 gene product in transitional cell carcinoma of the bladder.

Nakopoulou LL, Constandinides CA, Tzonou A, Lazaris AC, Zervas A, Dimopoulos CA.

Histopathology. 1996 May;28(5):429-35.

PMID:
8735718
11.

Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.

Sanchez-Carbayo M, Socci ND, Lozano J, Saint F, Cordon-Cardo C.

J Clin Oncol. 2006 Feb 10;24(5):778-89. Epub 2006 Jan 23.

PMID:
16432078
12.

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression.

Sarkis AS, Dalbagni G, Cordon-Cardo C, Zhang ZF, Sheinfeld J, Fair WR, Herr HW, Reuter VE.

J Natl Cancer Inst. 1993 Jan 6;85(1):53-9.

PMID:
7677935
13.

Predicting outcome in minimally invasive (T1a and T1b) urothelial bladder carcinoma using a panel of biomarkers: a high throughput tissue microarray analysis.

Mhawech-Fauceglia P, Fischer G, Alvarez V Jr, Ahmed A, Herrmann FR.

BJU Int. 2007 Nov;100(5):1182-7. Epub 2007 Jul 23.

14.

Genomic and proteomic profiles reveal the association of gelsolin to TP53 status and bladder cancer progression.

Sanchez-Carbayo M, Socci ND, Richstone L, Corton M, Behrendt N, Wulkfuhle J, Bochner B, Petricoin E, Cordon-Cardo C.

Am J Pathol. 2007 Nov;171(5):1650-8.

15.

Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness.

Shariat SF, Zlotta AR, Ashfaq R, Sagalowsky AI, Lotan Y.

Mod Pathol. 2007 Apr;20(4):445-59. Epub 2007 Mar 2.

16.
17.

[Expression of Survivin in transitional cell carcinoma of urinary bladder and its clinical significance].

Xiao ZJ, Zheng S, Chen W, Zhang HF, Li CL, Gao YN.

Zhonghua Yi Xue Za Zhi. 2004 Dec 2;84(23):1977-9. Chinese.

PMID:
15730809
18.

Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors.

Baumgart E, Cohen MS, Silva Neto B, Jacobs MA, Wotkowicz C, Rieger-Christ KM, Biolo A, Zeheb R, Loda M, Libertino JA, Summerhayes IC.

Clin Cancer Res. 2007 Mar 15;13(6):1685-94.

19.

p63 gene expression study and early bladder carcinogenesis.

Compérat E, Bièche I, Dargère D, Ferlicot S, Laurendeau I, Benoît G, Vieillefond A, Verret C, Vidaud M, Capron F, Bedossa P, Paradis V.

Urology. 2007 Sep;70(3):459-62.

PMID:
17905096
20.

Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.

Tut VM, Braithwaite KL, Angus B, Neal DE, Lunec J, Mellon JK.

Br J Cancer. 2001 Jan;84(2):270-5.

Supplemental Content

Support Center